What are the Rome IV diagnostic criteria for irritable bowel syndrome?

Rome Criteria for Irritable Bowel Syndrome

The current standard diagnostic criteria are the Rome IV criteria, which require recurrent abdominal pain at least 1 day per week in the last 3 months (with symptom onset at least 6 months prior), associated with two or more of the following: pain related to defecation, associated with a change in stool frequency, or associated with a change in stool form. 1

Core Diagnostic Requirements

The Rome IV criteria 1 represent the most recent iteration and differ importantly from their predecessors:

Rome IV Criteria (Current Standard)

• Recurrent abdominal pain (not discomfort) at least 1 day per week in the last 3 months
• Two or more of the following associations:
  • Pain related to defecation
  • Associated with change in stool frequency
  • Associated with change in stool form
• Criteria fulfilled for last 3 months with symptom onset at least 6 months before diagnosis

Key Differences from Rome III

The Rome IV criteria are substantially more restrictive than Rome III 2. The critical changes include:

1. Pain frequency increased from "at least 3 days per month" to "at least 1 day per week"
2. "Discomfort" removed - only abdominal pain qualifies
3. This resulted in approximately 50% reduction in IBS prevalence in community studies 1, 3

Clinical implication: About 15% of patients who met Rome III criteria do not meet Rome IV criteria, primarily due to insufficient pain frequency 3. These Rome IV-negative patients tend to have milder symptoms, less visceral hypersensitivity, and better quality of life 3.

Historical Context

Rome III Criteria (2007)

• Required abdominal pain or discomfort at least 3 days per month 2
• More sensitive but less specific than Rome IV
• Captured a broader, less severe patient population

Manning Criteria (Historical)

The original Manning criteria 2 included six features:

1. Pain relieved by defecation
2. More frequent stools at onset of pain
3. Looser stools at onset of pain
4. Visible abdominal distension
5. Passage of mucus per rectum
6. Sense of incomplete evacuation

Note: Manning criteria are more variable and less standardized, with prevalence estimates ranging from 2.5% to 37% depending on how many criteria are required 2.

Performance Characteristics

Rome IV Validation Data

In secondary care validation 4:

• Sensitivity: 82.4%
• Specificity: 82.9%
• Positive likelihood ratio: 4.82
• Negative likelihood ratio: 0.21

Rome IV performed significantly better than Rome III in this validation study, with Rome III showing sensitivity of 85.8% but specificity of only 65.0% 4.

Clinical Nuances

Important caveat: Recent research suggests the Rome IV criteria may be too restrictive for clinical practice 5. A modification relaxing pain frequency back to 3 days per month (while keeping "pain" rather than "discomfort") improved diagnostic performance with:

• Sensitivity: 90.2%
• Specificity: 85.1%
• Positive likelihood ratio: 6.06

IBS Subtypes

Once IBS is diagnosed, subtype classification uses Bristol Stool Form Scale 1:

• IBS-C (constipation): ≥25% hard stools (Bristol 1-2), <25% loose stools (Bristol 6-7)
• IBS-D (diarrhea): ≥25% loose stools, <25% hard stools
• IBS-M (mixed): ≥25% hard stools AND ≥25% loose stools
• IBS-U (unclassified): Does not meet criteria for other subtypes

Practical Application

When to Apply Rome IV Criteria

• Symptoms present ≥6 months to distinguish from transient conditions like infections 2
• Absence of alarm features (weight loss, rectal bleeding, nocturnal symptoms, anemia) 6
• Normal physical examination

Supportive Clinical Features 2

• Female sex (2:1 female predominance in younger patients)
• Age <45 years
• Symptoms aggravated by stress
• Frequent consultations for non-gastrointestinal symptoms
• Previous medically unexplained symptoms

Common Pitfall

Do not confuse continuous daily pain with IBS. Patients with continuous, unremitting abdominal pain likely have "functional abdominal pain syndrome," a distinct and more severe condition requiring different management 2.

Geographic and Cultural Considerations

Recent data from Southeast Asia 7 shows that only 31% of Rome III IBS cases remained classified as IBS under Rome IV criteria, with others reclassified as unspecified bowel disorder (24%) or functional constipation (17%). This highlights that Rome IV criteria identify a more severe, clinically distinct population across different geographic regions.